EcoDrugPlus

Bcl-2-Like Protein 1

Ensembl ID : ENSLCRG00005022429
Gene Symbol: LOC104939421
2 Cross references
216 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSLCRG00005018028
Gene Symbol: BACE1
3 Cross references
218 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSLCRG00005018328
Gene Symbol: BDKRB1
3 Cross references
147 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSLCRG00005018331
Gene Symbol: BDKRB2
3 Cross references
146 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSLCRG00005018332
Gene Symbol: BDKRB2
1 Cross references
167 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4b

Ensembl ID : ENSLCRG00005005034
Gene Symbol: LOC104927425
2 Cross references
224 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4b-Like

Ensembl ID : ENSLCRG00005002563
Gene Symbol: LOC104936185
2 Cross references
193 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1c Subunit

Ensembl ID : ENSLCRG00005019808
Gene Symbol: CACNA1C
3 Cross references
213 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1d Subunit, A

Ensembl ID : ENSLCRG00005007108
Gene Symbol: CACNA1DA
3 Cross references
211 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1f Subunit

Ensembl ID : ENSLCRG00005021100
Gene Symbol: CACNA1FB
3 Cross references
177 Possible Orthologues:

Calcium Channel, Voltage-Dependent, N Type, Alpha 1b Subunit, A

Ensembl ID : ENSLCRG00005006563
Gene Symbol: CACNA1BA
3 Cross references
219 Possible Orthologues:

Calcium Channel, Voltage-Dependent, P/q Type, Alpha 1a Subunit, B

Ensembl ID : ENSLCRG00005012831
Gene Symbol: CACNA1AB
3 Cross references
192 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).